Precision Health Solutions, LLC

Precision Health Solutions, LLC was paid $654K by Medicaid between Jul 2020 and Mar 2024, across 22 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	651	$470.00
2021	28,186	$168K
2022	71,999	$366K
2023	26,320	$117K
2024incomplete	1,042	$3K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	74%	42,296	7,546	$483K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	10%	41,381	7,380	$68K
81226		6.4%	778	441	$42K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	3.2%	4,421	611	$21K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.4%	5,336	2,025	$9K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.3%	1,314	270	$9K
81225		1.0%	720	415	$7K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	481	121	$6K
87631		<1%	188	102	$3K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	26,031	4,559	$3K
87481		<1%	829	338	$803.38
87640		<1%	633	293	$413.88

10 more codes

87641		<1%	368	$403.00
81227		<1%	322	$342.62
87653		<1%	528	$322.07
87500		<1%	485	$267.07
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	131	$105.00
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	116	$83.72
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	1,067	$25.93
87486		<1%	212	$16.46
87581		<1%	212	$16.46
81328		0%	349	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialORDONEZ, BRIGITHY (MEDICAL LABORATORY TECHNOLOGIST)